A study reports the prognostic significance of CALCRL gene expression in AML patients, suggesting its potential as a therapeutic target.
Studying CALCRL gene expression in larger cohorts and over longer follow-up periods is highly recommended to gain deeper insight into its functional role in oncogenesis and chemoresistance, as well as its potential as a molecular prognostic marker and future therapeutic target.
No takes yet. Share an insight, caveat, or question.
Khorshied et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: